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Abstract – Animmuneresponse(IR)indextoidentifycowswithhigh(H)andlow(L)antibody-
mediated immune responses (AMIR) had been previously devised. High AMIR associated
with decreased mastitis and improved response to vaccination. Measurement of cell-mediated
immune response (CMIR) was not included in the index; therefore various antigen/adjuvant
combinations were evaluated as inducers of DTH to be added to the IR-index. The Bacillus
Calmette Guérin (BCG)-induced/puriﬁed protein derivative (PPD)-elicited tuberculin skin test
is a reliable measure of DTH; however, its use to identify livestock with high CMIR may be
confounded due to previous exposure to Mycobacteria tuberculosis. DTH to BCG/PPD was
therefore compared with that induced by Mycobacteria phlei (saprophyte) and its derivative
phlein as the test antigen. Antibody to OVA was also evaluated. The results indicated that
BCG/PPD and M. phlei/phlein induced similar DTH, but cross reaction to PPD was evident
following induction of DTH using M. phlei making it a less than ideal alternative for testing
livestock. Nonetheless, cows could be ranked for both AMIR and CMIR. RNA from two cows
with the highest and lowest IR ranks was then used to probe a human 1.7 kD microarray to
determine the ability of a human array to provide information on bovine genes associated with
Ha n dL .
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1. INTRODUCTION
Improving both antibody (AMIR) and cell-mediated immune responses
(CMIR) may enhance resistance to infectious diseases of livestock. Studies of
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Yorkshire pigs selected for eight generations for high (H) and low (L) immune
responses based on combined estimated breeding values (EBV) of both AMIR
and CMIRdemonstratedhealthand productionbeneﬁts using a selectionindex
approach [10,23]. More recently, a mathematical index to identify periparturi-
ent cows with H, L, and average (A) serum AMIR has been devised and high
AMIRassociatedwithanincreasedresponsetovaccinationandwithdecreased
mastitisintwooutofthreeherdssurveyed[18]. However,anindicatorofCMIR
was not included in this index. An indicator of CMIR, such as delayed-type
hypersensitivity(DTH),couldlikelybeusedtoclassifycattleaswaspreviously
reported for pigs [10,23]. The combination of both AMIR and DTH may be
useful to classify and select cattle for broad-based disease resistance [11]. It is
therefore relevant to ﬁnd antigen-adjuvant combinations that elicit both AMIR
andCMIR,withtheheritablecharacteristicsrequiredtomakegeneticselection
feasible. The objectiveof thisstudy was to ﬁnd antigen-adjuvantcombinations
used in a simple, safe and effective immunization protocol that induce both
AMIR and CMIR, and will allow cows to be categorized as H, L or A based
on these responses. Categorization of cows based on AMIR and CMIR is a
ﬁrst steptowards the selectionof cattleforbroad-baseddiseaseresistance. The
possibility of using a human microarray to ﬁngerprint bovine genes associated
with H and L phenotypes was also investigated.
2. MATERIALS AND METHODS
2.1. Immunization protocols
Six groups of ﬁve non-lactating (dry) Holstein cows from 16 sires and
differentdamswererandomlyassignedtooneofthefollowingtreatmentgroups
(refer to Fig. 1 for an overview of treatments and immunization schedule): on
day 0, treatment group I (TG-I) received 1 mg of OVA (chicken albumin
grade VII) dissolved in 0.3 mL of phosphate buffered saline (PBS, pH 7.4) and
emulsiﬁed with 0.7 mL of non-ulcerative Freund adjuvant (NUFA; Cedarlane
Laboratories Ltd., Hornby, Ont., Canada). This group was considered the
DTH negative control since cows did not receive mycobacteria or any of its
components for induction of CMIR. Treatment group II (TG-II) received OVA
in PBS emulsiﬁed with 0.5 mL of FCA (0.5 mg heat-killed M. tuberculosis
H37Ra emulsiﬁed in water-in-mineral oil adjuvant, Sigma-Aldrich Canada
Ltd.) and 0.1 mL BCG (0.1 mg attenuated live M. bovis). This was considered
the DTH-positive control, since cows received both heat-killedM. tuberculosis
as a component of FCA and live M. bovis BCG. Treatment group III (TG-III)
received OVA in PBS emulsiﬁed with complete NUFA (CNUFA; 0.5 mg
killed Mycobacterium tuberculosis H37 RA, DIFCO Laboratories, Detroit,
MI., USA; emulsiﬁed in NUFA). Treatment group IV (TG-IV) received OVAHigh and low immune responsiveness in cattle S69
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Figure 1. The imunization schedule used to induce antibody to ovalbumin (OVA) and
delayed-type hypersensitivity (DTH) to mycobacteria.
in PBS together with 0.6 mg of Mycobacteriumphlei cell wall extract (MCWE
suspended in 0.4 mL of PBS, Vetrepharm, Inc., London, Ont., Canada) sus-
pended in 0.7 mL NUFA. Treatment group V (TG-V) received OVA in PBS
togetherwith0.6mgofMCWE,and0.1mLBCG.TreatmentgroupVI(TG-VI)
receivedOVAinPBStogetherwith0.6mgofMCWE.Allinjectionsweregiven
intramuscularly (IM), except for BCG, which was injected intradermally (ID).
Differentvolumesofdiluentsandadjuvantswereusedtoaccommodatedelivery
of equal mounts of antigen and to provide the manufacturer’s recommended
proportion of antigen-adjuvant in each treatment combination.
On day 14, TG-I, II and III were given 1 mg of OVA in PBS emulsiﬁed with
NUFA (0.7 mL), and TG-IV, V and VI received 1 mg of OVA in PBS together
with 0.6 mg of MCWE IM, in accordance with the homologous mycobacteria
species given on day 0.
2.2. Antibodies to ovalbumin (OVA)
Blood samples for determining serum antibody to OVA were taken on
days 0, 14 and 21. Antibodies to OVA were measured by enzyme-linked
immunosorbent assay (ELISA) as previously described [21].
2.3. Double skin-fold thickness as an indicator of DTH
On day 21, all cows were tested in accordance with the sensitizationantigen
received on day 0 with either 0.1 mL M. bovis PPD (250 US tuberculin units,S70 A. Hernández et al.
Canadian Food Inspection Agency, Nepean, Ont.) or 0.1 mg of M. phlei
PPD (phlein, kindly provided by Dr. Bob Duncan, Canadian Food Inspection
Agency)IDintherightandleftsideoftheneck. TG-I,IIandIIIweretestedwith
PPD, whereas TG-IV, V and VI were tested with phlein. The negative control
(TG-I)wastestedwithPPDsincethisistheregulatoryantigenforthetuberculin
(Tb) test. Double skin-fold thickness measurements (three repetitions) of each
site were taken with a spring-loaded caliper (Harpenden skin-fold caliper, Ann
Arbor,MI,USA)beforetheinjectionsonday21(h = 0)and6,24and48hafter
the injections. Delayed-type hypersensitivity was conﬁrmed by microscopic
evaluation (data not shown).
2.4. Variation in antibodies to OVA and DTH to mycobacteria
The cows of each treatment group were classiﬁed as high, low or average
immune responders based on their antibody to OVA on days 14 and 21 and
DTH response to mycobacteria at 24 and 48 h using the mean and standard
deviation of each group and response. Speciﬁcally, the OD of serum antibody
was used to classifycows forAMIR and the double skin-foldthicknesspercent
increase to PPD or phlein was used to classify cows for DTH. Those cows that
were above or below 1 standard deviation of the treatment group mean were
classiﬁedasHandL,respectively. Cowsbetweenbothstandarddeviationswere
classiﬁed as average (A). Lymphocyte proliferation assays using 5 µg · mL−1
concanavalin-A(Con-A)and80µg · mL−1 OVAwereperformed[9]toconﬁrm
theHorLphenotypeimmediatelypriortomicroarraygeneexpressionproﬁling.
2.5. Microarray gene expression proﬁling
Blood lymphocytes from two cows, one with the highest (cow 22) and one
with the lowest (cow 8) IR phenotypes (determined based on mean AMIR
and DTH responses +/− the standard deviation as described in section 2.4),
and having signiﬁcant differences (P ≤ 0.05) in lymphocyte blastogenesis to
Con-A and OVA immediately prior to collection of RNA were cultured in
complete IMDM (2.5 × 106 cells · mL−1) overnight at 37 ◦C and 5% CO2.
Total RNA was extracted for each experimental condition using the GenElute
Miniprep kit (Sigma-Aldrich Canada Ltd.). RNA from the H and L cows
was reverse transcribed, indirectly labeled with Cy5 (Red) or Cy3 (Green)
respectively, and hybridized to a 1.7 K human microarray according to the
manufacturer’s protocol [12]. Hybridized arrays were scanned on a GenePix
4000 Scanner (Axon Instruments Inc., Union City, CA, USA) and the images
were analyzed and tabulated using GenePix Pro 3.0 software. Following array
normalization and background subtraction using GenPix Pro 3.0, genes with
Cy5/Cy3 ratio intensities of greater than 2.0 or less than 0.5 in the OVA andHigh and low immune responsiveness in cattle S71
Con-A activated cultures were compared to the non-activated cultures (cells in
the medium alone).
2.6. Statistical analyses
The SAS® statisticalpackage [17] was used for most statisticalanalysesand
graphicpresentationof thedata. Theminimumlevelofsigniﬁcanceisreported
as P ≤ 0.05. The statistical analyses of AMIR, and DTH were performed
using a generallinearmixed model (PROC Mixed, SAS® ), and estimatedleast
squares means (LSM) were used in multiple comparisons. The AMIR and
DTH measurements were log transformed to normalize and analyze the data.
The model for AMIR was as follows:
yijk = cik + tj + fk + xjk + eijk
where: yijk = AMIR of cow i within the treatment group k at the time j of the
measurements; cik = cow (i = 5) within the treatment group k as a random
effect; tj = ﬁxed effect of time (j = 0, 14 and 21 days) of the measurements of
AMIR; fk = ﬁxed effect of the treatment group (k = 1 − 6); xjk = ﬁxed effect
of time by treatment group and eijk = random or residual error term.
The model for DTH was as follows:
yijklm = cik + tj + fk + sl + am + dmlik + hmk + gmj + xjk + zmjk + eijk
where: yijklm = DTH of cow i to antigen m by side l (left and right side of
the neck) within treatment group k at the time j of the skin measurements;
cik = cow (i = 5) within treatment group k as a random effect; tj = ﬁxed effect
of time (j = 0, 6, 24 and 48 h) of the measurements of DTH; fk = ﬁxed effect
of the treatment group (k = 1 − 6); sl = ﬁxed effect of side (l = left and right
side of the neck); am = ﬁxed effect of the antigen (m = PPD, phlein and PBS);
dmlik = random effect of antigen m by side l (left and right side of the neck)
by cow i within treatment group k; hmk = ﬁxed effect of antigen by treatment
group; gmj = ﬁxed effect of antigen by time; xjk = ﬁxed effect of time by
treatment group; zmjk = ﬁxed effect of antigen by time by treatment group and
eijk = random or residual error term.
The LSM for time by treatment by antigen were used to construct contrasts
using SAS® to obtain the increase of double skin-fold thickness from 0 to 6,
24 or 48 h post-injections and to compare responses among treatment groups.
Simple effects [20] Student t-tests, adjusted using Tukey HSD (honestly signi-
ﬁcant difference) approach [19], were used to decide if there were signiﬁcant
differences. The percent increase in double skin-fold thickness as an indicator
of DTH was computed as previously described [8].
Pearson correlations (Statistix, Analytical Software, USA) were computed
to examine the relationship between 21 day AMIR to OVA and DTH response
to mycobacteria at 24 and 48 h for TG-II – TG-V.S72 A. Hernández et al.
3. RESULTS
3.1. Antibodies to OVA
Primary (day 14) and secondary (day 21) serum antibody responses (P ≤
0.05) were observed in all treatment groups (Fig. 2a). Antibody responses to
OVA when given together with mycobacteria emulsiﬁed in a Freund adjuvant
(TG-II, TG-III, and TG-IV) tended to be greater than when given in MCWE
alone (TG-V and TG-VI).
3.2. DTH to mycobacteria
Percentincreaseofdoubleskin-foldthicknessasanindicatorofDTHamong
treatment groups is shown in Figure 2b. Cows which received mycobacteria
emulsiﬁed in a Freund adjuvant (TG-II, III, IV) had greater (P ≤ 0.05) DTH
responses than the negative control. Cows that received MCWE emulsiﬁed
in NUFA (TG-IV) also had DTH greater (P ≤ 0.05) than the positive control
at 24 h. Cows that received BCG and MCWE/phlein without an oil adjuvant
(TG-V) had relatively little DTH response but it was signiﬁcantly (P ≤ 0.05)
greater than the negative control at 24 h post-injection. Cows within TG-VI
(MCWE/phlein) showed no signiﬁcant DTH response.
3.3. Variation in antibodies to OVA and DTH to mycobacteria
ClassiﬁcationofcowsbasedonAMIRandDTHwithineachTGisillustrated
inTableI. TG-1(negativecontrol)andTG-VIdidnotinduceDTHandtherefore
cows receiving these treatments were not classiﬁed. Cows were ranked as H,
A or L responders based on primary and secondary serum AMIR on days 14
and 21, and DTH responses to mycobacteria observed at 24 and 48 h. Most
cows were within 1 standard deviation of the population mean and therefore
were classiﬁed as average responders. Few cows were H or L for both AMIR
and DTH or had opposing classiﬁcation for these two traits. Changes in clas-
siﬁcation over time (14 versus 21 days for AMIR and 24 versus 48 h for DTH)
occurredless frequentlybased on antibody(2/20 cows) than DTH (6/20 cows).
Two cows within TG-I and TG-III had neither primary (day 14) nor secondary
(day21)antibodyresponsestoOVAandthereforewereclassiﬁedasLantibody
responders. There was no statistical correlation between AMIR and DTH
responsesatanytimepoints,nonethelessitwasstillpossibletoﬁndsomecows
which had generally high (e.g. cow 22) or low (e.g. cow 8) immune responses.
3.4. Microarray analyses
Microarrayscans showed that mRNA from cows expressing H or L immune
responsephenotypes,andhavingsigniﬁcantly(P ≤ 0.05)differentlymphocyteHigh and low immune responsiveness in cattle S73
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Figure 2. (a) Comparison of serum antibody responses to ovalbumin (OVA) at 14
and 21 days following immunization. Bars indicate conﬁdence intervals; + indicates
greater (P ≤ 0.05) response than day 0; different letters indicate different (P ≤ 0.05)
responsesbetweentreatmentgroups. (b) Comparisonofdelayed-typehypersensitivity
(DTH)tomycobacteria(BacillusCalmetteGuérin(BCG),M.tuberculosisorM.phlei)
tested with either M. bovis puriﬁed protein derivative (PPD) or M. phlei PPD (phlein).
Bars indicate conﬁdence intervals; ∗ indicates greater (P ≤ 0.05) response than the
negative control (no mycobacteria and non- ulcerative Freund adjuvant); + indicates
greater (P ≤ 0.05) response than the positive control (BCG and Freund complete
adjuvant).S74 A. Hernández et al.
Table I. Classiﬁcation of cows based on antibody to ovalbumin (days 14 and 21) and
increase in double skin-fold thickness [delayed-type hypersensitivity (DTH) 24 and
48 h post-injection with M. bovis puriﬁed protein derivative (PPD) or M. phlei PPD
(phlein)].
Treatment group Cow # AMIR Day 14 AMIR Day 21 DTH 24 h DTH 48 h
II 6 H H A A
7A A A A
8L L L A
9A A H A
10 A A A H
III 11 A A A A
12 A A A A
13 A A A A
14 A A A A
15 L L H H
IV 16 A A H H
17 A A A A
18 A H A A
19 A A A A
20 L L A A
V2 1 A A A A
22 H H H A
23 A A A L
24 A L A A
25 A A A H
High (H), low (L), and average (A) responses were based on comparisons to the
population mean ±1 standard deviation within treatment groups. TG-I (negative
control) and TG-VI did not induce DTH and therefore, the cows in these treatments
were not classiﬁed.
blastogenicresponsestoOVAandCon-A(datanotshown)immediatelypriorto
collection of mRNA, will hybridize to a standardized commercially available
human array (Fig. 3). Therefore this approach could be utilized to identify
genes,whichdifferbetweenthesecows. Althoughonlytwocows(onewiththe
highest and one with the lowest immune response phenotype, cow numbers 22
and 8, respectively) were used to test this procedure, image analysis showed
that following lymphocyte stimulation with OVA, expression of 120 genes
differedbetween H and L (referto Tab. II for a selectedsample of these genes).
For example, CD14, high afﬁnity immunoglobulin epsilon receptor gamma-
subunit precursor (FCEG), and MAP kinase-activativated protein kinase 2High and low immune responsiveness in cattle S75
Figure 3. Different gene expression in 4 of 14 blocks of a 1.7 K human microarray
following hybridization of RNA from cows (n = 2) classiﬁed as high or low immune
responders. (This ﬁgure is available in color at www.edpsciences.org/gse).
(MKK2)genespotshadCy5/Cy3ratiosgreaterthan2.0(strongredsignalfrom
the H-responder cow); whereas, interleukin (IL)-1B, IL-11, natural killer cell
protein 4 precursor (NK4), and proteasome component C3 (PRC3) genes had
ratios less than 0.5 (strong green signal from the L-responder cow). Following
Con-A stimulation of lymphocytes from H and L cows, and hybridization of
mRNA to the array, only 51 genes showed Cy5/Cy3 ratios greater than 2.0
or less than 0.5. There was little overlap in the genes showing differential
expression following these two stimuli. At this point, these data can not infer
that these genes are markers for H and L immune responsiveness, but only
that this procedure can now be used to screen larger groups of cows classiﬁed
as H or L to obtain information on the genes which underpin these discrete
phenotypes.
4. DISCUSSION
Identiﬁcation of livestock with enhanced AMIR and CMIR has been pro-
posed as a means to improve broad-based resistance to infectious disease. In
fact, Yorkshire pigs selected simultaneouslyfor AMIR and DTH demonstrated
health and production beneﬁts [10,23]. Studies of Holsteins showed that cowsS76 A. Hernández et al.
Table II. Selected sample of genes from a 1.7 K human array with Cy5/Cy3 ratios
greater than 2.0 or less than 0.5 following hybridization of RNA after in vitro stimula-
tion of lymphocytes from two cows classiﬁed as high (red Cy5 labelled) or low (green
Cy3 labelled) immune responders with ovalbumin or concanavalin A.
(continued on the next page)
Abbreviations Gene name Gene bank
accession
number
OVA a
Ratio of
medians
ConAb
Ratio of
medians
A2MG Alpha-2-macroglobulin precursor W24394 0.336
0.299
2.133
2.367
AHNK Neuroblast differentiation associated
protein ahnak
AA044249 0.272
0.241
2.208
2.615
ANPA Atrial natriuretic peptide receptor A
precursor
R47859 0.183
0.182
–c
–
CD14 LPS receptor U00699 4.404
3.6
–
–
CD53 Leukocyte signal transducer MRC
OX44
AW768547 3.684
3.564
–
–
CD63 Granulophysin lysosomal-membrane
-associated glycoprotein 3
BQ787167 3.355
3.307
–
–
CD68 Melanoma-associated antigen (ME491) BQ549982 3.058
2.969
–
–
CD82 Leukocyte transducer 4F9 BI445391 2.316
2.22
–
–
CLK1 Protein kinase CLK1 AA046192 0.44
0.421
–
–
CN1B Calcium/calmodulin-dependent
3 ,5 -cyclic nucleotide
phosphodiesterase 1B
R24757 0.421
0.339
–
–
COF1 Coﬁlin, non-muscle isoform N39691 3.332
3.038
0.272
0.348
COXJ Cytochrome C oxidase polypeptide
VIIA-liver precursor
W78997 2.355
2.298
4.427
5.568
DDX5 Probable RNA-dependent helicase P68 W05242 0.436
0.375
0.343
0.418
FCEG High afﬁnity immunoglobulin epsilon
receptor gamma-subunit precursor
H71637 5.034
4.367
–
–
FRIH Ferritin light chain R81846 5.284
4.797
–
–
HB21 HLA class II histocompatibility
antigen, DQ(1) beta chain precursor
AA029822 –
–
0.165
0.169
IF4B Eukaryotic translation initiation
factor 4B
W32355 –
–
0.436
0.478
IL11 Interleukin 11 BG056707 0.245
0.185
–
–
IL1B Interleukin 1B BI335905 0.12
0.11
–
–
MKK2 MAP kinase-activated protein kinase 2 W69515 5.936
5.39
–
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Table II. Continued.
Abbreviations Gene name Gene bank
accession
number
OVA a
Ratio of
medians
ConAb
Ratio of
medians
MSH3 DNA mismatch repair protein MSH3 N44579 0.47
0.498
–
–
NK4 Natural killer cells protein 4 precursor AA131999 0.344
0.355
–
–
OB Leptin precursor H39701 0.297
0.351
6.352
6.253
PGH1 Prostaglandin G/H synthase 1 precursor R96180 4.436
4.002
–
–
PIMT Protein-L-isoaspartate(D-aspartate)
O-methyl transferase
H16888 0.519
0.468
–
–
PPP5 Serine/threonine protein phosphatase 5 AA023029 5.195
4.473
–
–
PRC3 Proteasome component C3 W52537 0.411
0.489
–
–
PRTP Lysosomal protective protein precursor W49687 –
–
4.465
4.293
RHOG RHO-related GTP-binding protein
RHOG
N94183 2.565
2.592
2.673
2.466
RL13 60S ribosomal protein L13 W52072 2.071
2.923
0.186
0.18
RL39 60S ribosomal protein L39 N53295 0.304
0.308
0.394
0.33
RS27 40S ribosomal protein S27 W21209 –
–
0.042
0.047
SAP Proactivator polypeptide precursor W67766 7.767
6.929
–
–
SOX4 Transcription factor SOX-4 W25479 –
–
0.246
0.316
SPIB Transcription factor SPI-B W01642 0.346
0.475
0.476
0.476
STCH Microsomal stress 70 protein ATPase
core precursor
R13040 0.178
0.15
–
–
TDX2 Thioredoxin peroxidase 2 W92854 –
–
6.007
5.411
TGFB Latent transforming growth factor beta
binding protein 1 precursor
AA044783 0.433
0.462
–
–
TPM4 Tropomyosin, ﬁbroblast non-muscle
type
W25296 4.506
4.495
–
–
TR12 Thyroid receptor interacting protein 12 AA195116 4
4.818
–
–
TRAD Tumor necrosis factor receptor type 1
associated protein
W32666 –
–
2.618
2.253
TSP1 Thrombospondin 1 precursor W47517 –
–
15.181
14.8
a Values in this column represent the ratio of Cy5/Cy3 medians for each of two duplicate gene
array spots following hybridization with mRNA from cells stimulated with OVA. b Values in this
column represent ratio of Cy5/Cy3 medians for each of two duplicate gene array spots following
hybridization with mRNA from cells stimulated with ConA. c (–) represents genes not expressed
in the speciﬁed range.S78 A. Hernández et al.
with high AMIR during the peripartum period had increased response to a
commercial J5 E. coli vaccine and reduced mastitis in two out of three herds
tested [21]. Therefore, the primary objective here was to ﬁnd antigen-adjuvant
combinations that induced both AMIR and CMIR, and which allowed cows to
be categorized as H or L. The secondary objective, having identiﬁed cows with
H and L immune response phenotypes, was to determine if a commercially
available human EST microarray could be used to detect possible genetic
differences between these phenotypes and to establish methods to utilize this
approach.
Primary (day 14) and secondary (day 21) antibody responses were observed
in each treatment group, indicating that all immunization protocols induced
antibody to OVA. A previous study of Holsteins during the peripartum period
also used OVA given in conjunction with a J5 E. coli vaccine to identify cows
with H or L AMIR [21]. Indeed, a variety of protocols have been successfully
used to effectively measure AMIR to OVA and classify cows (peripartum and
dry) [9,21].
In the current study, cows receiving mycobacteria emulsiﬁed in a Freund
adjuvant developed DTH, which varied substantially between individuals and
peaked24to48hpost-injectionofPPDorphlein. ThisDTHresponseissimilar
in time course to that described in other experiments [3,5]. Microscopically,
most of the signiﬁcant changes within treatment groups were observed in
inﬂammation,aswellasmacrophageandlymphocyteinﬁltration,andappeared
at 48 h post-injection.
The use of percent increase in double skin-fold thickness as a simple and
reliable indicator of DTH and as a means to identify H and L responders is
supportedhereinthatDTHresponsesvariedamongcowswithineachtreatment
(11.13–224.77% increase). Previous studies of pigs have also used a similar
method to select individuals with H and L DTH for selective breeding [8].
Cows within all treatments, except for the negative control (TG-1), and those
receiving OVA with MCWE alone (TG-VI), could be classiﬁed as H, L or A
for both AMIR and CMIR. Although this and a previous study [8] show no
positive correlation between AMIR and CMIR it is still possible to identify
some animals, which are H or L for both traits. Most cows had the highest
AMIRtoOVAatday21regardlessofthetreatmentgroup,andtheclassiﬁcation
as H or L was similar at days 14 and 21. However, classiﬁcation based on
DTH may vary between 24 and 48. Since differences in DTH responses over
time can affect cow classiﬁcation, it may be better to average 24 and 48 h
responses or to monitor response curve kinetics and chose the time that has
maximum genetic variation. Alternatively, DTH to multiple antigens could
be assessed, as is the case with DTH testing of humans [3,15]. Although
AMIR classiﬁcation varied little between primary and secondary responses,
ranking should be based on secondary responses in order to capture the abilityHigh and low immune responsiveness in cattle S79
to produce anamnestic responses. The lymphocyte proliferation assays using
Con-A and OVA performed prior to microarray gene evaluation of the highest
and lowest IR phenotypes (AMIR and DTH) conﬁrmed the H or L status.
Microarrayswereﬁrstusedin1995toanalyzedifferentialgeneexpressionin
Arabidopsis[18] and have since been effectivelyused to study gene expression
in a variety of species [1,2]. Although there are now at least two bovine
arrays available [14,24] these contain relatively few immune response genes
and were not available at the outset of this study. However, given the large
degreeofgenetichomologyamongmammalianspeciesitseemedreasonableto
testwhetherbovinemRNAcouldhybridizetoacommerciallyavailablehuman
array as a means to discover genes associated with these diverse phenotypes.
Microarray scans showed that mRNA from cows expressing H or L immune
response phenotypes will hybridize to a human array, and that this approach
could be utilized to identify genes that differ between these cows. Given that
these are only preliminaryexperimentsthis result can not infer that these genes
are markers for H and L immune responsiveness, but only that this procedure
can now be used to screen larger groups of cows classiﬁed as H or L to obtain
accurate information on genes which underpin these unique phenotypes.
5. CONCLUSIONS
Avarietyofphenotypicandgeneticmarkershavebeensuggestedtoselectfor
diseaseresistance[4]. However, giventhetremendouscapacityofpathogensto
vary their virulence mechanisms and that the immune system largely governs
response to infectious diseases, it may be better to attempt to enhance broad-
based disease resistance via enhanced immune responsiveness, rather than
to target speciﬁc diseases or pathogens. With this in mind, several studies
have sought to identify individuals within populations with H or L immune
responses. Studies of mice have shown that selection for H or L antibody to
sheep red blood cells is inversely associated with CMIR, and that the H anti-
body is associated with control of extracellular pathogens, but not intracellular
organisms [13]. Studies of chickens also selected for the H or L antibody have
reported similar ﬁndings [6,16]. However, selection of pigs for both H AMIR
and CMIR indicates health and production beneﬁts [8]. A recent study of
cows during the peripartum period also suggests beneﬁts to individuals with H
antibody responsiveness [22]. To reﬁne and improve this index, a simple, safe,
andeffectivemeanswassoughttoinducebothAMIRandCMIRforclassifying
H and L responders. The results of this study indicate that AMIR to OVA and
DTH to mycobacteria can be used to classify cows. Future studies will seek
to further reﬁne indicators of CMIR, determine associations with health traits,
and use microarrays as a means to discover genes which characterise these
phenotypes.S80 A. Hernández et al.
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